Harbourvest Partners LLC Arvinas, Inc. Transaction History

Harbourvest Partners LLC

  • $188 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022
SELL
$65.85 - $96.21 $1.39 Million - $2.03 Million
-21,111 Closed
0 $0
Q3 2021

Nov 15, 2021
BUY
$73.2 - $107.87 $1.55 Million - $2.28 Million
21,111 New
21,111 $1.74 Million
Q4 2020

Feb 16, 2021
SELL
$20.19 - $84.93 $336,486 - $1.42 Million
-16,666 Closed
0 $0
Q3 2020

Nov 12, 2020
BUY
$22.99 - $36.34 $383,151 - $605,642
16,666 New
16,666 $393,000

Others Institutions Holding ARVN

# of Institutions
229
Shares Held
68.4M
Call Options Held
226K
Put Options Held
285K
View Full List

About ARVINAS, INC.

ARVN Quotes by TradingView
  • Ticker ARVN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 53,205,300
  • Market Cap $997M
  • Description
  • Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...
More about ARVN
Track This Portfolio

Track Harbourvest Partners LLC Portfolio

Follow Harbourvest Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Harbourvest Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Harbourvest Partners LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email